UNSPSC 51292202: Flubepride

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UU4X6T9FT5. European Medicines Agency schedules Flubepride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07667MIG. Flubepride generally arises in the molecular formula C20H24FN3O4S.

UNSPSC 51292202 Flubepride is a Commodity code under which state and local governments procure naloxone and drug deactivation systems for public health and community safety initiatives. The recent solicitation activity shows demand for pharmaceutical and medical-device supplies supporting harm-reduction and substance-use programs, with vendors expected to provide products that meet regulatory compliance standards and deliver on established schedules to designated public facilities.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement requires electronic bid submission, inclusion of all shipping and delivery costs in pricing, drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and a two-year initial term with an optional one-year renewal. The contract includes a three-month probationary period and is potentially funded through FEMA, triggering additional federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises are specified in this opportunity.